APRICOT-2

APRICOT-2

Antithrombotics in the Prevention of Reoccclusion In COronary Thrombolysis. A trial comparing the efficacy of aspirin alone to aspirin plus medium-dose coumadin in preventing coronary reocclusion.
Conclusion Reocclusion in 30% of aspirin patients (A) vs 19% of combination patients (C); total occlusion in 19% of A vs 9% of C; freedom from death, reinfarction in 66% of A vs 86% of C.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.